Tumor-infiltrating lymphocytes as a feasible adjuvant immunotherapy for osteosarcoma with a poor response to

Jing Shi1, Ming Li1, Rongzhi Yang1

  • 1Department of Orthopedic Surgery, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang 471009, China.

Immunotherapy
|June 4, 2020
PubMed

Related Concept Videos